Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 7, 2012; 18(41): 5879-5888
Published online Nov 7, 2012. doi: 10.3748/wjg.v18.i41.5879
Published online Nov 7, 2012. doi: 10.3748/wjg.v18.i41.5879
Table 2 Time-course changes in hemoglobin concentration from baseline
| Week 2 of treatment | Week 4 of treatment | |
| Overall cohort | ||
| mean (SD), g/dL | -1.12 (1.13) | -2.31 (1.39) |
| Median (25th–75th quartile), g/dL | -1.05 (-1.8 to -0.3) | -2.3 (-3.2 to -1.3) |
| Derivation group | ||
| mean (SD), g/dL | -1.09 (1.11) | -2.27 (1.40) |
| Median (25th–75th quartile), g/dL | -1.0 (-1.8 to -0.3) | -2.3 (-3.1 to -1.3) |
| Confirmatory group | ||
| mean (SD), g/dL | -1.18 (1.17) | -2.33 (1.37) |
| Median (25th–75th quartile), g/dL | -1.1 (-1.95 to -0.4) | -2.3 (-3.3 to -1.35) |
-
Citation: Tsubota A, Shimada N, Abe H, Yoshizawa K, Agata R, Yumoto Y, Ika M, Namiki Y, Nagatsuma K, Matsudaira H, Fujise K, Tada N, Aizawa Y. Several factors including
ITPA polymorphism influence ribavirin-induced anemia in chronic hepatitis C. World J Gastroenterol 2012; 18(41): 5879-5888 - URL: https://www.wjgnet.com/1007-9327/full/v18/i41/5879.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i41.5879